alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
     (This schedule  contains summary financial  information  extracted from (A)
Consolidated Balance Sheets,  Statements of Operations,  Changes in Stockholders
Equity and Cash Flows and is  qualified in its entirety by reference to such (B)
Quarterly report on Form 10-Q for the three months ended March 31, 1998)
</LEGEND>
       
<S>                                     <C>
<PERIOD-TYPE>                           3-MOS
<FISCAL-YEAR-END>                       DEC-31-1998
<PERIOD-END>                            MAR-31-1998
<CASH>                                            0
<SECURITIES>                                      0
<RECEIVABLES>                                     0
<ALLOWANCES>                                      0
<INVENTORY>                                       0
<CURRENT-ASSETS>                                  0
<PP&E>                                            0
<DEPRECIATION>                                    0
<TOTAL-ASSETS>                                    0
<CURRENT-LIABILITIES>                         9,498
<BONDS>                                           0
<PREFERRED-MANDATORY>                             0
<PREFERRED>                                       0
<COMMON>                                     36,493
<OTHER-SE>                                  (45,991)
<TOTAL-LIABILITY-AND-EQUITY>                      0
<SALES>                                           0
<TOTAL-REVENUES>                                  0
<CGS>                                             0
<TOTAL-COSTS>                                     0
<OTHER-EXPENSES>                                811
<LOSS-PROVISION>                                  0
<INTEREST-EXPENSE>                                0
<INCOME-PRETAX>                                (811)
<INCOME-TAX>                                      0
<INCOME-CONTINUING>                            (811)
<DISCONTINUED>                                    0
<EXTRAORDINARY>                                   0
<CHANGES>                                         0
<NET-INCOME>                                   (811)
<EPS-PRIMARY>                                     0
<EPS-DILUTED>                                     0
        

</TABLE>
III 

109TH CONGRESS 

2D SESSION S. CON. RES. 123 

Providing for correction to the enrollment of the bill H.R. 5946. 

IN THE SENATE OF THE UNITED STATES 

DECEMBER 7, 2006 

Mr. STEVENS submitted the following resolution; which was considered and 

agreed to 

CONCURRENT RESOLUTION 

Providing for correction to the enrollment of the bill H.R. 

5946. 

1 Resolved by the Senate (the House of Representatives 

2 concurring) That, in the enrollment of the bill H.R. 5946, 

3 the Clerk of the House shall make the following correc4 tions: 

5 (1) In the table of contents, strike the item re6 lating to section 702 and redesignate the item relat7 ing to section 703 as relating to section 702. 

8 (2) In title VII, strike section 702 and redesig9 nate section 703 as section 702. 

Æ 


jcorcoran on PRODPC62 with BILLS
EX-4.05



 





Exhibit 4.05




CERTIFICATE OF TRUST



OF


CITIGROUP CAPITAL XXIII



     This Certificate of Trust is being executed as of November 15, 2007 for the purposes of
organizing a statutory trust pursuant to the Delaware Statutory Trust Act, 12 Del. C. §3801 et seq.
(the “Act”).



     The undersigned, the trustees of Citigroup Capital XXIII, hereby certify as follows:



     1. Name. The name of the statutory trust being formed hereby is “Citigroup Capital XXIII”
(the “Trust”).



     2. Delaware Trustee. The name and business address of the trustee of the Trust which has its
principal place of business in the State of Delaware are as follows:


The Bank of New York (Delaware)

100 White Clay Center

Route 273

P. O. Box 6995

Newark, DE 19711




     3. Effective. This Certificate of Trust shall be effective immediately upon filing in the
Office of the Secretary of State of the State of Delaware.





1









 





Dated: November 15, 2007




	 	 	 	 	 	 	 
	 

	 	By:
	 	/s/ John Gerspach
	 	 
	 

	 	 	 	 	 	 
	 	 	John Gerspach, as Regular Trustee
	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Eric L. Wentzel	 	 
	 

	 	 	 	 	 	 
	 	 	Eric L. Wentzel, as Regular Trustee
	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Saul Rosen	 	 
	 

	 	 	 	 	 	 
	 	 	Saul Rosen, as Regular Trustee
	 
	 	 	 	 	 	 
	 	 	THE BANK OF NEW YORK (DELAWARE),
	 	 	as Delaware Trustee
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Kristine K. Gullo	 	 
	 

	 	 	 	 	 	 
	 	 	Name: Kristine K. Gullo
	 	 	Title: Vice President
	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	CITIGROUP INC.,
	 	 	as Sponsor
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Charles E. Wainhouse	 	 
	 

	 	 	 	 	 	 
	 	 	Name: Charles E. Wainhouse
	 	 	Title: Vice President







2
Order entered May 1, 2020

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-20-00318-CV

B.G.C., Appellant

V.

M.Y.R., Appellee

On Appeal from the 429th Judicial District Court

Collin County, Texas

Trial Court Cause No. 429-05292-2018

ORDER

Before the Court is appellee’s April 30, 2020 unopposed motion for an 

extension of time to file her brief on the merits. We GRANT the motion and 

extend the time to May 20, 2020.

/s/ BILL WHITEHILL

JUSTICE
**Exhibit 32.1**

**WABCO HOLDINGS INC.**

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED**

**PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Annual Report of WABCO Holdings Inc. (the “Company”) on Form 10-K for the year ended December 31, 2007 as filed with the Securities and Exchange Commission on the date hereof (the “Report”),I, Jacques Esculier, the Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that 

(i) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as ofand for the periods covered in the Report. 

 

Dated: March 14, 2008
#### Braman *against*Hess.

Where on the endorsement of a note, the consideration passing between the endorsee and his endorser is not equal to the amount of the note, the endorsee, in an action against the endorser can only recover the consideration which he has actually paid.

*THIS*was án action of *assumpsit*by the endorsee against the endorser of a promissory note;; the cause, was tried at the *Mont* gomery*circuit, irj 1815,. before Mr. J. Yates. •

The note was for 343 dollars and 25 cents, and was 'dráwn by one *Edward Williams,*j.un., .in favour of the' defendant and *■John Yerdan,*and by them endorsed to the plaintiff. The defendan-t offered to show, in mitigation of damages, that the trans- ' fer of the note, by the endorser to the endorsee, was made on ' ■ *¿ ■ X*. ' , . . ' .. . , a discount of .90 dollars | but the judge rejected the.evidencej and a verdict was given for the plaintiff for the full amount of the note, with interest.

The defendant .moved for a new trial, and the casé was sub? rnitted without argument, .

*P-er Curiam.*

The evidence offered on the párt of the defendant ought to have been received, according to the principle which governed the case of *Wiffin*v. *Roberts,*(1 *Esp. Cas.*261.,) and. which was adopted and sanctioned by this; court in *Brown*v. *Mott,*(7 *Johns. Rep.*361.) This suit'is by the endorsee-against his immediate endorser. And in the case of *Livingston*v. *Hastie & Patrick,*(2 Caines’ Rep. 248.,) it is explicitly laid down, that the payee will be allowed, against the drawer, and the endorsee against his immediate endorser, to show what was the real consideration passing between them. If this suit was by the endorsee against the maker of the note, it would not-lie in his mouth to, say the plaintiff purchased it at a discount; but as the defendant was the immediate endorser of the plaintiff, the proof offered that the note was purchased for 90 dollars, under the face Of it,, should have been admitted. A Hew trial must, therefore, be granted, unless the plaintiff wilif pemit the 90 cjollais, and the interest which hag been vecovered fhcreon,
## Contact Information

Bethesda MD20892

dailz@mail.nih.gov

## Summary

Dr. Dai has a strong background in biology, immunology, microbiology, vaccinology, biochemistry, and clinical trials. She is skilled in using animal models and biological assays as well as flow cytometry and PCR. Her research experience includes DNA, RNA, and protein/polysaccharide purification and quantitation as well as human cell-line culture, PBMC/PMN isolation and differentiation, and antibody production. She is also proficient in sample preparation for flow cytometry, barcoding bio-specimens, vaccine characterization and proficiency evaluation, and GMP procedures.

## Research Statement

Dr. Dai’s current research focus is to characterize the immunologic aspects of vasculitis and relapsing polychondritis. She is involved in translational research related to the molecular classification of disease.

Previously, Dr. Dai studied vaccine development for TB and other diseases at the NICHD. She worked with bacterial pathogens and monoclonal antibodies for human use in addition to developing polysaccharide conjugate vaccines against bacterial infectious diseases for preclinical and clinical trials.

## Scientific Publications

###             Effects of infection and disease with Mycobacterium tuberculosis on serum antibody to glucan and arabinomannan: two surface polysaccharides of this pathogen.        

13().

###             Bacillus anthracis Capsular Conjugates Elicit Chimpanzee Polyclonal Antibodies That Protect Mice from Pulmonary Anthrax.        

22(8).

###             Pre- and postexposure protection against virulent anthrax infection in mice by humanized monoclonal antibodies to Bacillus anthracis capsule.        

108(2).

###             Antigenic evidence of prevalence and diversity of Mycobacterium tuberculosis arabinomannan.        

42(7).

###             Poly(gamma-D-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: a potential addition to the anthrax vaccine.        

100(15).

###             Specificity and diversity of antibodies to Mycobacterium tuberculosis arabinomannan.        

10(1).

###             Glucan is a component of the Mycobacterium tuberculosis surface that is expressed in vitro and in vivo.        

70(5).

###             Expression of a Mycobacterium tuberculosis arabinomannan antigen in vitro and in vivo.        

69(9).

## Education

**Capital Institute of Pediatrics, Beijing , China**M.D. (equivalent in US) Pediatrics

**Peking Union Medical College, Beijing, China**M.Sc. Microbiology & Immunology

**Capital Medical University, Beijing, China**B.S. Medicine

## Experience

**Biologist**LCMI NIAID NIH, Bethesda MD (2019-2020) 

**Medical Interpreter**Liberty Language Services, VA (2015-2020) 

**Research Scientist**PDMI NICHD,NIH, Bethesda MD (1997-2013) 

**Visiting Fellow**PDMI NICHD,NIH, Bethesda MD (1993-1996)

September 2021

Back to Top
Michigan Supreme Court

Lansing, Michigan

Robert P. Young, Jr., Chief Justice

Michael F. Cavanagh

Marilyn Kelly

Stephen J. Markman

Diane M. Hathaway

Mary Beth Kelly

Brian K. Zahra, Justices

I, Corbin R. Davis, Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

 _________________________________________

 Clerk

November 20, 2012

t1113

Order 

November 20, 2012

145891

PEOPLE OF THE STATE OF MICHIGAN,

Plaintiff-Appellee,

v SC: 145891

COA: 308949 

Allegan CC: 11-017094-FC

LEONARD EMERY NULL,

Defendant-Appellant. 

_________________________________________/

On order of the Court, the application for leave to appeal the August 8, 2012 order 

of the Court of Appeals is considered, and it is DENIED, because we are not persuaded 

that the questions presented should be reviewed by this Court.
Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF
2002

I, Richard W. Koe, certify to the best of my knowledge, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of TigerLogic Corporation on Form 10-Q for the quarterly period ended December 31, 2010 fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents in all material respects the financial condition and results of operations of TigerLogic Corporation for the periods presented
therein.

Date: February 11, 2011



By:

/S/    Richard W. KoeName:

Richard W. KoeTitle:

Interim President and Chief Executive Officer


I, Thomas Lim, certify to the best of my knowledge, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of
TigerLogic Corporation on Form 10-Q for the quarterly period ended December 31, 2010 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in
such Form 10-Q fairly presents in all material respects the financial condition and results of operations of TigerLogic Corporation for the periods presented therein.

Date: February 11, 2011



By:

/S/    Thomas LimName:

Thomas LimTitle:

Chief Financial Officer
#### State v. Chaplin

Case below: 180 N.C. App. 692

No. 030P07

Defs PDR Under N.C.G.S. 7A-31 (COA06-96)

Denied 05/03/07
Exhibit 23.1







Moffitt & Company, P.C.
------------------------------------------------
Certified Public Accountants                       5040 E. Shea Blvd., Suite 270
                                                   Scottsdale, Arizona  85254
                                                   (480) 951-1416
                                                   Fax (480) 948-3510
                                                   moffittcpas@eschelon.com


                         CONSENT OF INDEPENDENT AUDITORS


June 25, 2003


Reconditioned Systems, Inc.
444 W. Fairmont
Tempe, AZ  85282

Dear Sir or Madam:

We do hereby consent to the use in this Form 10-KSB dated June 25, 2002 of our
report dated May 6, 2002 relating to the March 31, 2002 audited financial
statements of Reconditioned Systems, Inc.

Sincerely,



/s/ Stanley M. Moffitt

Stanley M. Moffitt, CPA
Moffitt & Company, P.C.
TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

NO. 03-21-00655-CV

In re Sergei Anatolyevich Ivanov

ORIGINAL PROCEEDING FROM WILLIAMSON COUNTY

M E M O R A N D U M O P I N I O N

The petition for writ of mandamus is denied. See Tex. R. App. P. 52.8(a). Real 

Party in Interest’s request for attorneys’ fees is also denied.

__________________________________________

Chari L. Kelly, Justice

Before Chief Justice Byrne, Justices Kelly and Smith

Filed: January 7, 2022
Exhibit 31.2I, John A. Betts, certify that:1. I have reviewed this annual report on Form 10-K of Centrue Financial Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading with respect to the periodcovered by this report; 3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results ofoperations and cash flows of the registrant as of, and for, the periods presented in thisreport; 4. The registrant’s other certifying officer(s) and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have: a) designed such disclosure controls and procedures, or caused such disclosurecontrols and procedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including its consolidated subsidiaries, ismade known to us by others within those entities, particularly during the period inwhich this report is being prepared;  b) [intentionally omitted]  c) evaluated the effectiveness of the registrant’s disclosure controls andprocedures and presented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by this reportbased on such evaluation; and  d) disclosed in this report any change in the registrant’s internal control overfinancial reporting that occurred during the registrant’s most recent fiscal quarter(the registrant’s fourth fiscal quarter in the case of an annual report) that hasmaterially affected, or is reasonably likely to materially affect, the registrant’sinternal control over financial reporting; and5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and theaudit committee of the registrant’s board of directors (or persons performing the equivalentfunctions): a) all significant deficiencies and material weaknesses in the design or operationof internal control over financial reporting which are reasonably likely to adverselyaffect the registrant’s ability to record, process, summarize and report financialinformation; and  b) any fraud, whether or not material, that involves management or other employeeswho have a significant role in the registrant’s internal control over financialreporting.   Date: March 23, 2006 /s/ John A. Betts     John A. Betts  Corporate Controller and Interim Principal  Financial Officer
&

^ X

IN THE COURT OF CRIMINAL APPEALS OF TEXAS

JOEY FAUST, Appellant

FILED IN

COURT OF CRIMINALAPPEALS

March 24, 20l£

ABEL ACOSTA, CLERK

v. § NO. PD-0893-14

THE STATE OF TEXAS, Appellee §

RAMON MARROQUIN, Appellant §

§ NO. PD-0894-14

THE STATE OF TEXAS, Appellee §

ON DISCRETIONARY REVIEW OF CAUSE NUMBERS

02-13-00222-CR and 02-13-00223-CR IN THE

COURT OF APPEALS FOR THE SECOND DISTRICT OF TEXAS

APPELLANTS' MOTION FOR LEAVE TO FILE

APPELLANTS' POST-SUBMISSION BRIEF

(-

J. SHELBY SHARPE

State Bar No. 18123000

utlawman@aol.com

6100 Western Place, Suite 1000

Fort Worth, Texas 76107

(817) 338-4900/Fax (817)332-6818

ATTORNEY FOR APPELLANTS
STATEMENT OF HELPFULNESS

OF POST-SUBMISSION BRIEF

During oral argument several questions were asked about other court

opinions related to certain issues before the Court in this appeal. A postsubmission brief provides the Court with answers to those questions citing

pertinent language from the opinions the Court inquired about. Furthermore, the

sincere questions of the Court indicate a desire to fully understand the relationship

of First Amendment speech protection as it applies to proper law enforcement to

protect public tranquility and safety.

WHEREFORE, PREMISES CONSIDERED, Appellants Joey Faust and

Ramon Marroquin respectfully pray that the Court grant leave to file Appellant's

Post-Submission Brief.

Respectfully submitted,

/s/ J. Shelby Sharpe

J. SHELBY SHARPE

State Bar No. 18123000

utlawman@aoI.com

6100 Western Place, Suite 1000

Fort Worth, Texas 76107

Telephone: (817) 338-4900

Facsimile: (817) 332-6818

ATTORNEY FOR APPELLANTS

JOEY DARRELL FAUST AND

RAMON MARROQUIN
CERTIFICATE OF SERVICE

A true and correct copy of Appellant's Motion for Leave to File PostSubmission Brief has been served on Charles M. Mallin, Assistant Tarrant County

District Attorney, 401 W. Belknap St., Fort Worth, Texas 76196-0201, on this 23rd

day of March, 2015, via electronic mail.

/s/ J. Shelby Sharpe

J. Shelby Sharpe
**Exhibit 31.1**

 

**CERTIFICATION**

 

I, James C. Flores, Chairman of the Board, President and Chief Executive Officer of Plains Exploration & Production Company, certify that: 

 

1. I have reviewed this annual report on Form 10-K/A of Plains Exploration &Production Company; 

 

2. Based on my knowledge, this report does notcontain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by thisreport; 

 

3. Based on my knowledge, the financial statements, and otherfinancial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 

 

4. The registrant’s other certifying officer and I are responsible forestablishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) [omitted in accordance with section III.E. of SEC Release No. 34-47986] for the registrant and we have: 

 

a. designed such disclosure controls and procedures, or caused suchdisclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularlyduring the period in which this report is being prepared; 

 

b. [omitted in accordance with section III.E. of SEC Release No. 34-47986]; 

 

c. evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about theeffectiveness of the disclosure controls and procedures, as of the end of the period covered by this report, based on such evaluation; and 

 

d. disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’smost recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed,based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function): 

 

a. all significant deficiencies and material weaknesses in the design or operation of internal controls over financialreporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

 

b. any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internalcontrols over financial reporting.
##### 



EXHIBIT 12.2
  STERLING
    FINANCIAL CORPORATION
  COMPUTATION
    OF RETURN ON AVERAGE ASSETS
 For the
    Year Ended December 31, 2006
  Total AssetsYTD12/31/2005


7,558,928,17501/31/2006


7,600,862,80902/28/2006


7,693,454,64803/31/2006


7,840,285,16604/30/2006


7,992,914,74405/31/2006


8,047,524,16506/30/2006


8,044,338,49507/31/2006


8,724,345,93708/31/2006


8,888,408,03009/30/2006


8,912,717,41110/31/2006


9,010,195,08411/30/2006


9,038,688,82912/31/2006


9,828,651,810109,181,315,303Number of Months


13Average


8,398,562,716Net Income

$
73,946,355ROA


0.88
%